A Randomized, Blinded-assessor, Single Center Study to Determine if Administration of Sugammadex, When Used to Reverse Deep Neuromuscular Blockade (NMB) After Open Abdominal Surgery, Impacts Hospital Efficiency
Phase of Trial: Phase IV
Latest Information Update: 14 Nov 2017
At a glance
- Drugs Sugammadex (Primary) ; Glycopyrrolate; Neostigmine
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 07 Nov 2017 Planned End Date changed from 1 May 2017 to 1 Feb 2018.
- 07 Nov 2017 Planned primary completion date changed from 1 May 2017 to 1 Feb 2018.
- 11 Aug 2016 New trial record